Modalities for the removal of beta 2-microglobulin from blood
1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Abstract:
The long-term accumulation of beta(2)-microglobulin (beta(2)M) in patients with kidney failure results in a debilitating condition referred to as dialysis-related amyloidosis (DRA). There have been few methods specifically designed to remove the large quantities of beta(2)M that are produced by the body. This article briefly reviews current modalities and concepts for the removal of beta(2)M from blood. The various approaches are classified according to the mechanism of beta(2)M clearance. The potential application of immunoadsorption, a biologically specific approach to remove macromolecules, in the treatment and understanding of DRA is discussed.
Related Concept Videos
Drug Elimination by Renal Route: Tubular Secretion
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration


